Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
CJC-1295 and Ipamorelin remain investigational with limited safety data and specific FDA concerns regarding compounding
Bottom panel: 8-Isoprostane levels were reduced by 35% in the low dose group (gray bar) at week 2
It has been noted by previous research that agents that, unlike GHRH, which interacts with the GHRH receptors, molecules that interact with the ghrelin receptors may have low specificity and support multiple streams of pituitary hormone
This pulsatile pattern, combined with preserved somatostatin-mediated feedback, distinguishes ipamorelin from continuous GH delivery and is the reason it appears frequently in protocols designed to study pituitary axis regulation rather than simply elevate circulating GH
US$ 25.92
US$ 26.28
US$ 22.49
